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Abstract
Background
Schistosomiasis is a neglected disease affecting hundreds of millions worldwide. Of the
three main species affecting humans, Schistosoma haematobium is the most common, and
is the leading cause of urogenital schistosomiasis. S. haematobium infection can cause dif-
ferent urogenital clinical complications, particularly in the bladder, and furthermore, this par-
asite has been strongly linked with squamous cell carcinoma. A comprehensive analysis of
the molecular composition of its different proteomes will contribute to developing new tools
against this devastating disease.
Methods and findings
By combining a comprehensive protein fractionation approach consisting of OFFGEL elec-
trophoresis with high-throughput mass spectrometry, we have performed the first in-depth
characterisation of the different discrete proteomes of S. haematobium that are predicted to
interact with human host tissues, including the secreted and tegumental proteomes of adult
flukes and secreted and soluble egg proteomes. A total of 662, 239, 210 and 138 proteins
were found in the adult tegument, adult secreted, soluble egg and secreted egg proteomes,
respectively. In addition, we probed these distinct proteomes with urine to assess urinary
antibody responses from naturally infected human subjects with different infection intensi-
ties, and identified adult fluke secreted and tegument extracts as being the best predictors
of infection.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007362 May 15, 2019 1 / 23
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Sotillo J, Pearson MS, Becker L,
Mekonnen GG, Amoah AS, van Dam G, et al.
(2019) In-depth proteomic characterization of
Schistosoma haematobium: Towards the
development of new tools for elimination. PLoS
Negl Trop Dis 13(5): e0007362. https://doi.org/
10.1371/journal.pntd.0007362
Editor: Alessandra Morassutti, PUCRS, BRAZIL
Received: December 20, 2018
Accepted: April 5, 2019
Published: May 15, 2019
Copyright: © 2019 Sotillo et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Mass spectrometry
data along with the identification results have been
deposited to the ProteomeXchange Consortium via
the PRIDE partner repository with the dataset
identifiers PXD011137 and 10.6019/PXD011137.
Funding: This work was supported by a program
grant from the National Health and Medical
Research Council (NHMRC - https://nhmrc.gov.au/
) [program grant number 1037304] and a Senior
Principal Research fellowship from NHMRC to AL
(1117504). The funders had no role in the study
Conclusion
We provide a comprehensive dataset of proteins from the adult and egg stages of S. haema-
tobium and highlight their utility as diagnostic markers of infection intensity. Protein compo-
sition was markedly different between the different extracts, highlighting the distinct subsets
of proteins that different development stages present in their different niches. Furthermore,
we have identified adult fluke ES and tegument extracts as best predictors of infection using
urine antibodies of naturally infected people. This study provides the first steps towards the
development of novel tools to control this important neglected tropical disease.
Author summary
Schistosomiasis is a neglected tropical disease affecting millions of people worldwide. Of
the main three species affecting humans, Schistosoma haematobium is the most common,
and is the leading cause of urogenital schistosomiasis. This parasite can cause a range of
clinical complications associated with bladder pathogenesis, including squamous cell car-
cinoma as well as genital malignancy in women. Herein, we have performed the first com-
prehensive characterisation of the proteins implicated in host-parasite interactions
(secreted and surface proteins from the adult flukes and secreted and soluble egg proteins)
in order to advance our understanding of the parasite’s biology. Furthermore, we have
characterised the different antibody responses in urine from infected human subjects
from an endemic area presenting different infection intensities. The data obtained in this
study can be used as a first step towards the development of novel tools for the control of
urogenital schistosomiasis.
Introduction
Schistosomiasis is a neglected tropical and debilitating disease caused by different trematodes
from the genus Schistosoma [1]. It affects over 250 million people worldwide, particularly in
developing and tropical regions [2–4]. Despite widespread use of the anthelmintic praziquantel
in mass drug administration programs over the last 30 years [5], this parasitic infection still
causes a loss of 1.9 million disability-adjusted life years (DALYs) [6], and this number could be
greater if morbidity associated with asymptomatic infections was included in the calculations
[7]. Of the 6 species affecting humans, S. haematobium is the most common, causing urogeni-
tal schistosomiasis in over 100 million people [1], although it is considered the neglected schis-
tosome since the amount of “omics” information is scarce compared to other schistosomes
and the difficulty in maintaining the parasite in an animal model [8, 9]. S. haematobium infec-
tion has been reported in 54 countries [10], particularly in sub-Saharan Africa and the Middle
East [2, 3]. Furthermore, an outbreak of urogenital schistosomiasis was observed in Corsica
(France) [11], although this parasite has recently been shown to be a hybrid between S. haema-
tobium and Schistosoma bovis. [12].
The clinical complications associated with urogenital schistosomiasis are linked among oth-
ers, to bladder pathology [13]. The association between squamous cell carcinoma and S. hae-
matobium infection is undisputed [14]; indeed, this blood fluke has been classified as a Class I
carcinogen by the International Agency for Research on Cancer (IARC) [15]. Once established
in the mesenteric veins surrounding the bladder, S. haematobium adult females start laying
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eggs that pass through the bladder epithelium to be secreted in the urine. However, some eggs
get trapped in the bladder wall causing a chronic local inflammation that will develop into a
granuloma accompanied by relentless cell proliferation and ultimately in some patients, blad-
der cancer [16] as well as genital malignancy in women [17, 18]. The initial inflammatory
response is thought to be a reaction to mechanical damage caused by passing of eggs through
the urothelium (a multilayered epithelium that lines most of the urogenital tract) [13]; how-
ever, proteins secreted by parasite eggs have also been shown to increase cell proliferation and
angiogenesis [13]. One of the most abundant proteins secreted by S. haematobium eggs is the
IPSE, or interleukin-4 inducing principle from Schistosoma mansoni eggs. IPSE induces cell
proliferation and angiogenesis [13, 19], and an IPSE homologue from S. haematobium has
been shown to attenuate inflammation by stimulating release of IL-4 [19, 20].
Despite the clear role of soluble egg proteins in the development of granulomas and a carci-
nogenic environment, the protein composition of this or other S. haematobium tissues/organs
has not been fully characterised, although a few studies have identified several immunogenic
proteins [21]. In contrast, different proteomes from the related species S. mansoni, S. japoni-
cum and even from the cattle-infecting S. bovis have been well characterised [22–26], which
has allowed for the identification of novel vaccine and diagnostic antigen candidates. Indeed,
different tegumental and secreted proteins are potential vaccine candidates and some have
entered or completed Phase I and II clinical trials [27]. The most progressed vaccine candidate
for S. haematobium infection is glutathione S-transferase (Sh28GST), which completed Phase
III clinical testing in 2012 [28] but the results have yet to be published [29].
Characterising the molecular interface of host-parasite interactions in S. haematobium
infection is crucial for (i) a better understanding of the parasite’s biology and, (ii) for the devel-
opment of new tools for control and diagnosis. In the present study, we provide the first in-
depth identification of secreted and surface proteomes of S. haematobium. We also character-
ise the antibody responses in urine from infected human subjects from an endemic area pre-
senting different infection intensities as a first step towards the development of novel
diagnostic tools against this devastating disease.
Results
Schistosoma haematobium tissue proteomes involved at the host-parasite
interface
The proteomes from different parasite extracts involved in host-parasite interactions, such as
the adult ES and tegument proteins as well as the egg ES and soluble egg antigen (SEA) pro-
teins were characterised by LC-MS/MS. To limit the number of false identifications we
appended 116 sequences of common contaminants to the S. haematobium protein database
(Bioproject PRJNA78265, www.parasite.wormbase.org/), and only proteins identified with�2
peptides were considered as positively identified. The extract with the highest number of iden-
tified proteins was the adult tegument (662, S5 Table), followed by adult ES (239, S6 Table),
SEA (210, S7 Table) and egg ES (138, S8 Table). The adult tegument sample also had the high-
est number of unique (only present in this extract) proteins (430), followed by SEA (61), adult
ES (48) and egg ES (19) (Fig 1A). Furthermore, adult tegument and adult ES proteins had 85
proteins in common, while only 57 proteins were commonly identified in all datasets (Fig 1A).
The top 25 most abundant proteins in each extract selected based on the spectral count pro-
vided a similar profile: 12 proteins were uniquely identified in adult tegument extract, followed
by SEA (11) and adult ES and egg ES (8 each) (Fig 1B). Only 3 proteins were commonly identi-
fied in all datasets (MS3_04307.1, fatty acid binding protein—FABP; MS3_11229.1, triose
phosphate isomerase; and MS3_06482.1, glutathione S-transferase—GST). Unique proteins
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Fig 1. Proteins identified in the different Schistosoma haematobium proteomes. (A) The numbers and intersections of the identified
proteins from different Schistosoma haematobium proteomes was visualised using an Upset plot. Connected dots display shared proteins
between datasets, and the total number of proteins identified in a particular dataset is indicated in the set size. (B) Venn diagram representing
the intersection of the top 25 most abundant proteins from each dataset based on spectrum counting.
https://doi.org/10.1371/journal.pntd.0007362.g001
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identified from the adult tegument included three hypothetical proteins (MS3_07454.1,
MS3_09812.1 and MS3_01840.1), one tetraspanin (Sh-TSP-2) and two annexins (MS3_087
23.1 and MS3_05924.1), among others (Fig 1B). Among the proteins uniquely identified
in SEA, we found two proteins of the glioma pathogenesis related-1 (GLIPR1) subfamily
(MS3_11039.1 and MS3_07294.1), IPSE/alpha-1 protein (MS3_10186.1), as well as several
enzymes (MS3_08600.1, MS3_10510.1 and MS3_00286.1) (Fig 1B). A calcium binding protein
(MS3_00183.1), alpha-tubulin (MS3_02314.1), thioredoxin (MS3_09682.1) and a major egg
antigen (MS3_11428.1) were the most highly represented proteins uniquely identified in egg
ES, while uniquely identified proteins in adult ES included saposin (MS3_02805.1) and thymo-
sin (MS3_03084.1).
Protein families and functions in the different proteomes of Schistosoma
haematobium
A Pfam analysis was performed on the different proteomes from S. haematobium and the top
25 most represented protein families for each dataset were visualized in a heatmap (Fig 2). Five
different protein domains (three different EF-hand-like domains, a tetratricopeptide repeat
and an AAA domain) were highly represented in all proteomes, while three domains were
exclusively found in proteins identified in the tegument of S. haematobium (ADP-ribosylation,
Ras family and Ras of Complex Roc) (Fig 2). Similarly, one domain was found in proteins
exclusively identified in the egg ES (KH domain), while other cytoskeletal and redox domains
(e.g. redoxin, tropomyosin and glutathione S-transferase) were more abundant in proteins
from egg ES and SEA. Interestingly, two immunoglobulin domains were highly represented in
the proteins identified from the adult ES and also found in the adult tegument but not present
in any of the egg proteomes (Fig 2).
The GO analysis was performed using Blast2GO [30] and biological processes and molecu-
lar functions plotted using ReviGO [31]. Several metabolic processes were highly represented
in adult ES (S9 Table), together with “gluconeogenesis” and “proteolysis” (Fig 3A). An “oxida-
tion-reduction process” was common between adult ES and tegument proteomes, while the
tegument proteins were also involved in “phosphorylation” (Fig 3C, S10 Table). Regarding
molecular functions inferred from adult ES and tegument proteins, both datasets were
enriched in “oxidoreductase activity”, “ATP binding”, “transferase activity” and “cytoskeletal
protein binding”, although presenting different scores and frequencies (Fig 3C and 3D).
Both egg ES and SEA had distinct profiles with regards to the terms associated with biologi-
cal process (S11 and S12 Tables, respectively). Despite both proteomes contain proteins
involved in “gluconeogenesis” and “proteolysis”, they had different associated metabolic pro-
cesses (Fig 4A and 4C). Two molecular function terms were similar among all proteomes
(“oxidoreductase activity”, “ATP binding”), while “protein binding” was exclusively found in
egg ES and SEA (Fig 4B and 4D). In addition, the egg ES proteome was enriched in proteins
involved in “kinase activity” and “calcium ion binding”, while the molecular functions in SEA
proteins related to “transferase activity” and “metal ion binding” (Fig 4B and 4D).
Schistosoma haematobium secreted and tegument proteins have potential
as diagnostic markers of infection
Using the different S. haematobium proteomes characterized in this study, we analyzed anti-
body responses in the urine of S. haematobium-infected individuals (Fig 5A–5D) to the various
parasite extracts. Furthermore, the AUC generated from the ROC curves were used to deter-
mine the sensitivity and specificity of each antibody response, and the predictive value of infec-
tion (Fig 6A–6D). Antibodies to all extracts were significantly reactive in the urine of all
Proteomes of Schistosoma haematobium
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subjects with a high egg count (>50 eggs/ml) compared to non-endemic negative controls
with the most significant reactivity being to adult fluke ES and SEA (p<0.0001), although
adult tegument and egg ES samples were also highly reactive (p<0.001). Antibodies in the
urine of subjects with a medium intensity infection (11–50 eggs/ml) significantly reacted to all
extracts, compared to non-endemic negative controls, with the most significant reactivity
being to adult ES and tegument extracts (p<0.01). Interestingly, the antibody levels in the
urine of subjects with low intensity infection (0.3–10 eggs/ml) were significantly elevated only
for adult ES (p<0.05) and not for other extracts tested, while subjects with a very low level of
infection (egg-negative by microscopy but CAA-positive) had significantly elevated antibody
levels to only adult tegument and SEA extracts (p<0.05).
The highest predictive value of infection in subjects with a high egg count was generated by
the antibody response to adult ES (AUC 0.9954), followed by adult tegument (0.977), egg ES
(0.9288) and SEA (0.9101) antibody responses. In the case of subjects with a medium egg
count, the highest predictive value of infection was also observed with adult ES antibody
Fig 2. Pfam analysis. The top 25 most represented protein families from every proteome analysed were visualised using a heatmap. Values represent the
abundance (in percentage) of each protein family relative to the total number of protein families present in each proteome.
https://doi.org/10.1371/journal.pntd.0007362.g002
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responses (0.9707), followed by adult tegument (0.8661), SEA (0.7691) and egg ES (0.7449).
This was again the case for subjects with a low egg count; the predictive value of infection for
adult ES, adult tegument, SEA and egg ES antibody responses being 0.7612, 0.6518, 0.702 and
0.5435, respectively. Interestingly, the highest predictive value of infection in microscopy egg
negative but CAA positive subjects was generated with the antibody response to adult tegu-
ment extract (0.9762), followed by SEA (0.869), adult ES (0.8333) and egg ES (0.5357).
Discussion
Despite accounting for almost two-thirds of all cases of schistosomiasis [32], S. haematobium
remains the most neglected schistosome of medical importance in terms of laboratory research
effort, partly due to the lack of proteomic and genomic information (which underpin knowl-
edge of the parasite’s biological and pathogenic processes) [8]. Several versions of the S. man-
soni genome have been published [33, 34], as well as numerous high-throughput proteomes
from different life stages [22, 24–26, 35, 36]; however, only one version of the genome and
very few proteins have been characterised for the causative agent of urinary schistosomiasis
[37]. Indeed, a thorough examination of the S. haematobium genome failed to detect the pres-
ence of a homologue of Sm-TSP-2 in this parasite, despite this protein being found in the
proteomic datasets described herein, its abundance in S. mansoni proteomes [38] and the
Fig 3. Gene ontology analysis of the adult excretory/secretory (ES) and tegument protein preparations from Schistosoma haematobium. Gene ontologies
of proteins from S. haematobium adult ES (A, B) and tegument (C, D) were ranked by nodescore (Blast2GO) and plotted using ReviGO. Figure shows
Biological Processes (A, C) and Molecular Function (B, D). Semantically similar GO terms plot close together, circle size denotes the frequency of the GO term
from the underlying database, and increasing heatmap score signifies increasing nodescore from Blast2GO.
https://doi.org/10.1371/journal.pntd.0007362.g003
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presence of numerous homologs in S. japonicum [39]. Sm-TSP-2 has proven to be one of the
most effective vaccine candidates against schistosomiasis [40, 41] and has successfully under-
gone a phase I clinical trial [42]; confirmation of the existence of a S. haematobium orthologue
is important, therefore, to determine whether a similar (or existing) vaccination strategy might
be effective against this species of schistosome. This example highlights the importance of the
availability of proteomic data to complement and, as is being increasingly reported, re-anno-
tate existing genomes to provide a comprehensive picture of the makeup of an organism [43].
Proteins at the interface between the host and the parasite are believed to play a key role in
host immune system modulation and parasite survival [43] and so characterisation of these
molecules is desirable to further our knowledge of parasite biology and pathogenesis and inter-
vention targets. For example, the proteins secreted and located on/in the tegument of the
blood-dwelling adult fluke are immune-accessible, and egg ES molecules are involved in the
generation of a tumorigenic environment [13] and can be studied to gain insight into host
pathogenesis.
A total of 57 proteins were commonly identified in all proteomic datasets generated.
Among these, MS3_04307.1 (FABP), MS3_11229.1 (triose phosphate isomerase) and
MS3__06482 (GST) were highly abundant. All proteomes were enriched in three main protein
families: AAA domains, EF-hand like domains and tetratricopeptide repeat (TPR) domains.
Fig 4. Gene ontology analysis of the egg excretory/secretory (ES) and soluble egg antigens (SEA) from Schistosoma haematobium. Gene ontologies of
proteins from S. haematobium egg ES (A, B) and SEA (C, D) were ranked by nodescore (Blast2GO) and plotted using ReviGO. Figure shows Biological
Processes (A, C) and Molecular Function (B, D). Semantically similar GO terms plot close together, circle size denotes the frequency of the GO term from the
underlying database, and increasing heatmap score signifies increasing nodescore from Blast2GO.
https://doi.org/10.1371/journal.pntd.0007362.g004
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Fig 5. Urine antibody levels against different Schistosoma haematobium antigen preparations. OD values
determined by ELISA using urine from individuals with different infection intensities based on egg counts (high,
medium, low and egg negative/CAA positive) from an endemic area of Zimbabwe against different proteomes from S.
haematobium. A control group of urine from non-endemic individuals who had never been infected with S.
haematobium was included. Adult excretory/secretory (ES) products (A), tegument proteins (B), egg ES (C) and
soluble egg antigen (D). Statistical analysis was performed using a non-parametric Kruskal-Wallis test with multiple
comparisons by Dunn’s post-test. � P < 0.05, �� P < 0.01, ��� P < 0.001, ���� P < 0.0001.
https://doi.org/10.1371/journal.pntd.0007362.g005
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The high abundance of proteins containing these domains suggests a vital role for these motifs
in parasite development and/or survival. While AAA domain-containing proteins such as
dyneins participate in a variety of functions and are ubiquitously present in many organisms
[44], EF-hand domain proteins are expressed almost uniquely by parasitic worms (highly
abundant in trematodes), and have been suggested to be an effective drug target [45]. TPR is a
structural repeat found in diverse proteins. In Schistosoma mekongi it is present within an O-
glycosyltransferase that is abundantly expressed by female flukes [46], while in S. japonicum,
the protein SJCHGC06661 was the highest immunoreactive protein in a protein array screened
against the serum from S. japonicum infected patients. This protein contains six TPR domains,
interacts with the heat shock protein (HSP) complex and has been suggested as a potential
drug or vaccine target [47].
The most complex mixture of proteins was identified in the adult tegument sample (662
proteins). Previous studies on S. mansoni schistosomula and S. japonicum adult flukes identi-
fied 450 and 360 proteins, respectively [22, 48], highlighting the complex composition of this
structure, probably due to an adaptive response to living in the harsh environment of the host
circulatory system. The molecular functions associated with these proteins correspond to the
functions observed in other studies [48]. For instance, proteins involved in several binding
functions (the highest represented function in the proteins identified in the S. japonicum adult
Fig 6. Receiver operating characteristic (ROC) curves. Areas under the ROC curve determine the predicative performance of adult excretory/secretory (ES)
products (A), tegument proteins (B), egg ES products (C) and soluble egg antigen (SEA) (D) to detect antibodies in the urine of individuals with differing
intensities (high, medium, low and egg negative/CAA positive) of Schistosoma haematobium infection. A control group of urine from non-endemic individuals
who had never been infected with S. haematobium was included.
https://doi.org/10.1371/journal.pntd.0007362.g006
Proteomes of Schistosoma haematobium
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007362 May 15, 2019 10 / 23
tegument [48]) such as metal ion binding, cytoskeletal protein binding and ATP binding were
highly represented in this study. Several molecular functions associated with protection against
oxygen-reactive species and redox systems such as oxidoreductase activity and transferase
activity were also highly represented, as expected in the tegument of a parasitic helminth
which is under constant immune threat [49]. Among the most abundant proteins present in
the tegument of S. haematobium adult flukes, we identified a putative GPI-anchored protein
similar to Sm29 (MS3_03973.1), a tetraspanin similar to Sm-TSP-2 (Sh-TSP-2), an aquaporin
(MS3_05757.1), as well as two different annexins (MS3_08723.1 and MS3_05924.1) and sev-
eral hypothetical proteins (MS3_07454.1, MS3_09812.1 and MS3_01840.1). Sm29 has been
shown to be an immunoregulatory molecule able to control inflammatory mucosal diseases
with both Th1 and Th2 immune response profiles [50] and can interact with CD59, an inhibi-
tor of the membrane attack complex (MAC), which could contribute to immune evasion [51].
Tetraspanins have a role in maintaining the structure of the tegument and providing stability
[52]. Interestingly, Sm29 and Sm-TSP-2, as well as the above-mentioned GST and FABP, are
important vaccine candidates [27]. Characterising the rest of the identified proteins, particu-
larly the hypothetical proteins, will improve the rational selection of vaccine candidates for S.
haematobium infection.
Using an older version of the S. haematobium proteome present in WormbaseParasite, only
379 proteins were predicted to be secreted by S. haematobium, making it the parasitic helminth
with the lowest number of predicted secreted proteins of the 44 species assessed [53]. In our
analysis, we found 239 proteins in the adult ES products, which accounts for more than 63% of
the total predicted secretome. The most abundant domains identified by Cuesta-Astroz in the
predicted secretome were PF00053 (Laminin-EGF), which was not highly represented in our
analysis, and PF13895 (Immunoglobulin domain), which was one of the most abundant fami-
lies in the adult ES dataset. We also identified the Immunoglobulin I-set domain as an abun-
dant protein in the adult ES products, which is also one of the most commonly occurring
proteins in the predicted helminth secretomes [53], and is present in cell adhesion molecules.
Interestingly, some of the identified proteins such as saposin, dynein and tetraspanins have
been previously identified in the extracellular vesicles (EVs) of S. mansoni [54, 55]. EVs have
not yet been described from S. haematobium, although it is tempting to speculate that some of
the proteins we identified in ES products are of vesicular origin.
Egg secretions from trematodes likely result from an active secretion process of the miracid-
ium enclosed within the egg and, in the case of S. haematobium, the proteins secreted by the
egg might not only reflect the biology of the miracidium stage, but might also be of importance
in the development of fibrosis and cancer. Among the top 25 most abundant proteins in all
datasets, 8 proteins were uniquely identified in the egg secretions, including calcium-binding
protein (MS3_00183.1), alpha-tubulin (MS3_02314.1), thioredoxin (MS3_09682.1), polymor-
phic mucin variant (MS3_01478.1) and the major egg antigen (MS3_11428.1). The calcium-
binding protein is orthologous (90% identity) to S. mansoni calmodulin, which has been
reported as an essential protein for egg development [56]. Indeed, calmodulin inhibitors can
disrupt egg hatching and interrupt miracidium transformation into sporocyst [57, 58]. The
polymorphic mucin variant has been identified in the miracidium of S. mansoni as having a
key role in invertebrate host/parasite interactions [59], and a family of S. mansoni polymorphic
mucins has been hypothesized to act as a smoke-screen blocking pattern recognition receptors,
thus avoiding recognition by the host immune system [59].
Different proteins with a role in defence against oxidative stress, such as GST and thiore-
doxin, were abundant in the egg ES proteome; as well as two triose phosphate isomerases,
which are proteins implicated in glycolysis and energy production. Interestingly, two homo-
logs of programmed cell death protein 5 (PCDC5; MS3_11526.1) and the major egg antigen
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also known as Smp40 (MS3_11428.1) were also uniquely identified in the egg ES and are
among the top 25 most abundant proteins. PCDC5 has a wide variety of biological functions,
including programmed cell death and immune regulation [60], and a decrease in the levels of
this protein has been associated with multiple types of cancers [60]. Smp40 is associated with
reduced collagen deposition, decreased fibrosis, and granuloma formation inhibition [61].
Active secretion of these two molecules might reflect an effort from the parasite to minimize
the potential fibrosis and cell proliferation induced by other proteins present in the egg shell.
Two GLIPR1 proteins (MS3_11039.1 and MS3_07294.1) were uniquely identified in the
SEA dataset and were among the most abundant proteins based on spectrum counting. These
proteins belong to the sperm-coating proteins/Tpx1/Ag5/PR-1/Sc7 (SCP/TAPS) family, and
have been identified in other trematodes including Fasciola hepatica [62] as well as other hel-
minths [63]. Although the exact function for these proteins is still unknown, this family of pro-
teins is expanded in the genomes and secreted proteomes of clade IV and V nematodes [64–
68] and is believed to play specific biological functions in the host including defence against
host attack and determination of lifespan [69]. The presence of these proteins in the eggs of S.
haematobium is intriguing and their roles in this life stage warrants exploration.
The IPSE/alpha-1 glycoprotein (MS3_ 10186.1) is a well characterized molecule from the
eggs of S. mansoni. It is located in the subshell area of mature eggs [70] and is a potent driver
of IL-4-mediated Th2 responses [70–73]. Furthermore, it induces a potent anti-inflammatory
response by inducing regulatory B cells to produce IL-10 [71]. The S. haematobium homolog
of IPSE/alpha-1 (H- IPSE) infiltrates host cells and translocate to the nucleus [19] and, inter-
estingly, has been shown to alleviate the symptoms of chemotherapy-induced hemorrhagic
cystitis [20].
With a view to providing the first steps towards the characterisation of novel molecules that
could be used for immunodiagnosis of S. haematobium infection, we assessed the levels of IgG
antibodies present in the urine of patients from an endemic area in Zimbabwe against the dif-
ferent extracts analysed in the study. Even though the presence of antibodies in serum or urine
cannot be used to differentiate previous and current infections, the detection of immunoglob-
ulins against parasites is still a useful diagnostic tool for surveillance, and can be helpful for
evaluating the effectiveness of control programmes [74]. Antibody detection diagnostics can
also be used to complement less sensitive point-of-care (POC) diagnostic tests, such as micro-
scopic detection of eggs in urine, in areas of low transmission. Some efforts have been made to
develop highly sensitive and specific tests for S. haematobium infection. For instance, diverse
parasite proteomes such as SEA, cercarial antigen preparation (CAP) and soluble worm anti-
gen preparation (SWAP) have been tested [75]. In this study, SEA and CAP were more reactive
than SWAP, which is in accordance with previous findings [74, 76–78]. The fact that SWAP is
not a good extract from a diagnostic point of view could be because it is highly abundant in
intracellular proteins that will never be exposed to host antibodies. The detection of antibodies
against SEA and SWAP in the urine of human subjects with schistosomiasis has been previ-
ously reported [74, 77, 78], but the presence and diagnostic utility of urine antibodies to adult
fluke tegument and ES have not been described. Herein, we highlight the diagnostic capability
of arguably more immunologically relevant proteomes, in addition to SEA, to detect antibod-
ies in the urine of infected individuals, and show that the adult fluke ES and tegument prepara-
tions were more reactive than SEA for all of the cohorts studied. Antibodies can be detected in
urine of subjects infected with both S. mansoni and S. japonicum (where eggs are passed in the
stool instead of urine), so the presence of antibodies in urine of subjects infected with S. hae-
matobium is likely due to clearance of IgG from circulation through the kidneys as opposed to
vascular leakage due to bladder pathology caused by parasite eggs. However, despite the fact
that the prevalence of S. mansoni compared to S. haematobium infection is very low in
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Zimbabwe, especially in the areas where the samples were collected [75, 79], we cannot exclude
a role for S. mansoni infection in the responses observed. Future studies aimed at characteris-
ing species-specific diagnostic molecules will address this point.
We have provided the first comprehensive high-throughput analysis of the proteins present
in different S. haematobium proteomes of importance in host/parasite interactions, thereby
facilitating a snapshot of the molecular biology of the parasite and how it interacts with the
host. In addition, we have identified adult fluke ES and tegument extracts as best predictors of
infection when probed with antibodies from the urine of infected human subjects. This com-
bined study of proteomic characterisation and serodiagnostic analyses provide the first steps
towards the characterisation of novel molecules that could serve as tools for the control and
evaluation of S. haematobium infection in Sub-Saharan Africa.
Materials and methods
Ethics
The collection of urine from individuals from Zimbabwe was approved by the Medical
Research Council of Zimbabwe; Approval MRCZ/A/1710.
All experimental procedures involving animals reported in the study were approved by the
James Cook University (JCU) animal ethics committee (ethics approval number A2391). The
study protocols were in accordance with the 2007 Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes and the 2001 Queensland Animal Care and Protection
Act.
Human Schistosoma haematobium parasitology
Urine samples from naturally infected individuals were collected on three consecutive days for
parasitological examinations. S. haematobium infection was detected by microscopic examina-
tion of the parasite eggs in 10ml urine, processed using the standard urine filtration method
[80]. For each participant, infection intensity was expressed as the arithmetic mean of egg
counts per 10 mL urine of samples collected on consecutive days. Urines were stratified
according to WHO classification as having either a high (>50 eggs/10 ml of urine), medium
(11–49 eggs/10ml of urine) or low (0.3–10 eggs/10 ml of urine) level of infection [81]. Egg neg-
ative urines (0 eggs/10 ml of urine) were tested for the presence of circulating anodic antigen
(CAA–a more sensitive diagnostic test than microscopic detection of eggs in urine) using the
UCAA2000 (wet format) as described previously [82] to confirm the presence or absence of
infection.
Parasite material
S. haematobium-infected Bulinus truncatus snails were provided by the National Institute of
Allergy and Infectious Diseases (NIAID) Schistosomiasis Resource Center for distribution
through BEI Resources, NIAID, National Institutes of Health (NIH), USA: S. haematobium,
Egyptian strain, exposed B. truncatus subsp. truncatus, NR-21965. Snails were removed from
their tank, washed with water and transferred to a petri dish without light or water at 27˚C for
90 minutes. They were then rinsed again and water was added to an approx. depth of 3–5 mm.
Snails were then placed under direct light maintaining a temperature of 28–30˚C for 1–2
hours. The water was then transferred to a new petri dish through a sieve with 20 μm pore size
to concentrate cercariae. Water was transferred from the snails to the sieve every 20 min three
more times while cercariae continued to be shed. Mice (6 week-old Balb/c) were infected with
1,000 cercariae by tail penetration and adult worms were recovered by vascular perfusion at 16
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weeks p.i. [83]. Eggs from livers of perfused mice were isolated according to the method of
Dalton et al. [84] to obtain highly purified ova that were free of host debris.
Isolation of adult excretory/secretory products
Two hundred freshly perfused adult fluke pairs were washed 3× in serum-free Basch media
supplemented with 4× antibiotic/antimycotic (10,000 units/mL of penicillin, 10,000 μg/mL of
streptomycin, and 25 μg/mL of Amphotericin B) (AA) (Thermo Fisher Scientific, USA) [85]
followed by incubation in the same medium at 37˚C, 5% CO2 at a density of *50 fluke pairs
in 4 mL of medium for 7 days. Culture medium was changed after 4 hours and discarded to
minimize the presence of host contaminants from regurgitating flukes. Media was subse-
quently changed every day and dead flukes removed from the plate to avoid contamination
with somatic proteins. The excretory/secretory (ES) material was collected each day, centri-
fuged at 500 g, 2,000 g and 4,000 g to remove parasite debris, buffer exchanged in PBS, concen-
trated using a 10 kDa spin concentrator (Merck Millipore, USA), protein quantified by BCA
(Thermo Fisher Scientific, USA), aliquoted and stored at -80˚C until use.
Tegument extraction
Extraction of tegument proteins from adult flukes was performed using the freeze/thaw/vortex
technique as described previously [22, 86]. Briefly, two batches of 50 freshly perfused adult
fluke pairs were washed 3× in PBS, frozen at -80˚C, thawed on ice, washed in TBS (10 mM
Tris/HCl, 0.84% NaCl, pH 7.4) and incubated for 5 min on ice in 10 mM Tris/HCl, pH 7.4.
Each sample was vortexed for 5 × 1 s bursts, the tegument extract pelleted at 1,000 g for 30 min
and solubilized three times in 200 μl of solubilizing solution (0.1% (w/v) SDS, 1.0% (v/v) Tri-
ton X-100 in 40 mM Tris, pH 7.4) with pelleting at 15,000 g between each wash. The washes
were combined and buffer exchanged and concentrated as described above.
Egg excretory/secretory products and soluble egg antigen
Purified eggs were cultured in serum-free Basch medium supplemented with 4× AA (50,000
eggs/5 ml) for 72 hours at 37˚C with 5% CO2. Medium containing egg ES products was har-
vested every 24 hours and processed as described for adult ES. Approximately 400,000 eggs
were used for ES generation. To obtain SEA, freshly isolated eggs in PBS (100,000/ml) were
homogenized in a hand-held Potter-Elvehjem glass homogeniser (15 ml capacity), centrifuged
at 200 g for 20 min at 4˚C and then the supernatant centrifuged at 100,000 g for 90 min at 4˚C
[83]. The supernatant was then processed as described for adult ES.
OFFGEL electrophoresis
OFFGEL fractionation was performed for adult ES, adult tegument and egg ES samples as
described by Sotillo et al. [64]. A total of 100 μg of protein was resuspended in 50 mM
NH4CO3, 20 mM DTT and incubated at 65˚C for 1 h. Alkylation was then achieved by adding
iodoacetamide (IAM) to 55 mM and incubating the solution for 40 min in darkness at room
temperature (RT). A final incubation with 100 mM DTT was performed at RT before adding
2 μg of trypsin and incubating overnight at 37˚C. Fractionation of samples was performed
using a 3100 OFFGEL fractionator and OFFGEL kit (pH 3–10; 24-well format) (Agilent Tech-
nologies, Australia) according to the manufacturer’s protocols. Briefly, resultant peptides were
diluted in peptide-focusing buffer, 150 μL of sample was loaded into each of the 24 wells and
the sample was focused in a current of 50 μA until 50 kilovolt hours was reached. Each of the
fractions was collected, dried under a vacuum centrifuge and resuspended in 10 μL of 0.1%
Proteomes of Schistosoma haematobium
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007362 May 15, 2019 14 / 23
TFA before being desalted using a Zip-Tip (Merck Millipore, USA). Finally, samples were
dried again under a vacuum centrifuge and stored at -80˚C until use.
Mass spectrometry
Due to limited availability of material because of the difficulty in maintaining S. haematobium
in mice, different numbers of biological replicates were run for each sample. A total of 48 offgel
fractions from 2 different biological replicates (24 samples each) were run for adult ES, 48 off-
gel fractions from 2 different biological replicates (24 samples each) for adult tegument pro-
teins, 24 offgel fractions (from 1 replicate) for egg ES and 2 samples (from 2 replicates) for
SEA.
All samples were analyzed by LC-MS/MS on a Shimadzu Prominance Nano HPLC coupled
to a Triple Tof 5600 mass spectrometer (ABSCIEX) using a nano electrospray ion source. Sam-
ples were resuspended in 30 μl of solvent A (0.1% formic acid (aq)) and fifteen μl was injected
onto a 50 mm x 300 μm C18 trap column (Agilent Technologies) at a rate of 60 μl/min. The
samples were desalted on the trap column for 6 minutes using solvent A at the same rate, and
the trap column was then placed in-line with an analytical 150 mm x 100 μm 300SBC18,
3.5 μm nano HPLC column (Agilent Technologies) for mass spectrometry analysis. Peptides
were eluted in a linear gradient of 2–40% solvent B (90/10 acetonitrile/ 0.1% formic acid (aq))
over 80 min at 500 nL/min flow rate after 6 minutes of wash at 2% solvent B and followed by a
steeper gradient from 40% to 80% solvent B in 10 min. Solvent B was held at 80% for 5 min for
washing the column and returned to 2% solvent B for equilibration prior to the next sample
injection. Mass spectrometer settings were: ionspray voltage = 2,200V, declustering potential
(DP) = 100V, curtain gas flow = 25, nebuliser gas 1 (GS1) = 12 and interface heater = 150˚C.
The mass spectrometer acquired 250 ms full scan TOF-MS data followed by 20 by 250 ms full
scan product ion data in an Information Dependent Acquisition (IDA) mode. Full scan
TOF-MS data was acquired over the mass range 300–1600 and for product ion ms/ms 80–
1600. Ions observed in the TOF-MS scan exceeding a threshold of 150 counts and a charge
state of +2 to +5 were set to trigger the acquisition of product ion, ms/ms spectra of the resul-
tant 20 most intense ions. The data was acquired using Analyst TF 1.6.1 (ABSCIEX).
Database search and protein identification
Peak lists obtained from MS/MS spectra were identified using a combination of five search
engines in SearchGUI version v3.3.3 [87] since it has been shown that combining multiple
search engines increases the confidence of identified peptide spectrum matches (PSMs), dis-
tinct peptide sequences and proteins [88]. The search engines used were: X!Tandem version X!
Tandem Vengeance (2015.12.15.2) [89], MS-GF+ version Release (v2018.04.09) [90], Comet
version 2018.01 rev. 0 [91], MyriMatch version 2.2.140 [92] and Tide [93].
Protein identification was conducted against a concatenated target/decoy version of the S.
haematobium proteome downloaded from Parasite Wormbase (version of 2017-05-WormBase
- www.parasite.wormbase.org, 11,140 sequences) and concatenated to the common repository
of adventitious proteins (cRAP, https://www.thegpm.org/crap/, 116 sequences) and the
sequence of an antigen ortholog to S. mansoni TSP-2 that was obtained from GenBank
(MK238557) (total of 11,257 (target) sequences). The decoy sequences were created by revers-
ing the target sequences in SearchGUI. The identification settings were as follows: Trypsin spe-
cific with a maximum of 2 missed cleavages, 10.0 ppm as MS1 and 0.2 Da as MS2 tolerances;
fixed modifications: Carbamidomethylation of C (+57.021464 Da), variable modifications:
Deamidation of N (+0.984016 Da), Deamidation of Q (+0.984016 Da), Oxidation of M (+-
15.994915 Da), fixed modifications during refinement procedure: Carbamidomethylation of C
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(+57.021464 Da), variable modifications during refinement procedure: Acetylation of protein
N-term (+42.010565 Da), Pyrolidone from E (-18.010565 Da), Pyrolidone from Q (-17.026549
Da), Pyrolidone from carbamidomethylated C (-17.026549 Da). All algorithm specific settings
are listed in the Certificate of Analysis available in S1–S4 Tables.
Peptides and proteins were inferred from the spectrum identification results using Peptide-
Shaker version 1.16.27 [94]. PSMs, peptides and proteins were validated at a 1.0% False Dis-
covery Rate (FDR) estimated using the decoy hit distribution. All validation thresholds are
listed in the Certificate of Analysis available in the S1–S4 Tables. Mass spectrometry data along
with the identification results have been deposited to the ProteomeXchange Consortium via
the PRIDE partner repository [95] with the dataset identifiers PXD011137 and 10.6019/
PXD011137.
Bioinformatic analysis of proteomic sequence data
The programs Blast2GO v5.2 [30] and HMMER v3.1b1 [96] were used to classify the pro-
teins according to GO categories and Pfam domains respectively. Pfam domains were
detected at the P<0.01 threshold for the HMMER software. ReviGO was used to visualise
GO terms using semantic similarity-based scatterplots [31]. The UpSetR package (v. 1.3.3)
[97] was used to visualise the intersections of proteins between samples by producing
UpSetR plots in R.
Enzyme-linked immunosorbent assay with human urine
The urine of infected individuals (n = 98) from an area in Zimbabwe endemic for S. haemato-
bium infection was analyzed by ELISA using all S. haematobium protein preparations
described earlier. Urine from Australian volunteer donors that had never travelled to schisto-
somiasis endemic areas was used as a negative control (n = 14).
Polystyrene microtiter plates (Greiner Bio-One, Austria) were coated overnight at 4˚C
with 50 μl/well of a 5 μg/ml solution of S. haematobium adult ES, adult tegument, SEA or
egg ES in 0.1 M carbonate coating buffer, pH 9.6. The plates were washed three times with
PBS/0.05% Tween20 (PBST) and blocked for two hours at 37˚C using 5% skimmed milk in
PBST, followed by three wash steps in PBST for 15 min each. Plates were then incubated
with 50 μl of urine (diluted 1:5 in PBS) and incubated at 37˚C for 1.5 h followed by 3 washes
using PBST. Fifty μl of HRP-conjugated polyclonal anti-human IgG (Sigma-Aldrich) was
added at dilution of 1:5,000 and incubated for 1 hour at 37˚C. Finally, plates were washed
3× with PBST and incubated with 3,3’,5,5;-tetramethylbenzidine (TMB, Thermo Fisher Sci-
entific, USA) for 10 min at RT in the dark. The reaction was stopped by adding 3 M HCl
and absorbance read at 450 nm using a POLARstar Omega spectrophotometer (BMG Lab-
tech, Australia).
Statistical analysis
GraphPad Prism 7.0 was used for statistical analyses. Differences in antibody titers were ana-
lysed using the non-parametric Kruskal-Wallis test with Dunn’s multiple comparisons test.
Receiver Operating Characteristic (ROC) curves were used to calculate sensitivity, specificity
and the area under the curve (AUC). The AUC is a global measure of diagnostic accuracy and
indicates the probability of accurately identifying true positives, where a value of 0 indicates a
perfectly inaccurate test and a value of 1 reflects a perfectly accurate test [98].
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